AI Platform for Dementia
Dementia Disorders (e.g., Alzheimer's Disease)
Pre-clinicalActive
Key Facts
Indication
Dementia Disorders (e.g., Alzheimer's Disease)
Phase
Pre-clinical
Status
Active
Company
About LikeMinds
LikeMinds is a private, early-stage digital health company leveraging artificial intelligence to address significant unmet needs in neurological and mental health, specifically targeting tremor and dementia disorders. The company is led by Chairman and CEO Peter G. Savas, a seasoned life sciences executive, and benefits from a board that includes prominent clinician-scientists like Dr. Henry Brem of Johns Hopkins. Operating in a high-growth market, LikeMinds appears to be in a pre-revenue or early development stage, building its AI platform and likely seeking partnerships and funding to advance its technology toward clinical validation and commercialization.
View full company profile